YDES — YD Bio Balance Sheet
0.000.00%
HealthcareAdventurousMicro Cap
Annual balance sheet for YD Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 0.043 | 0.096 | 3.14 | 6.05 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.038 | 0.098 | 0.263 | 0.712 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Current Assets | 0.127 | 0.272 | 3.47 | 9.67 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.06 | 0.014 | 0.088 | 0.068 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 0.227 | 0.321 | 6.86 | 13.8 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.17 | 0.298 | 0.263 | 1.64 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.217 | 0.298 | 0.274 | 16.6 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 0.009 | 0.023 | 6.59 | -2.86 |
| Total Liabilities & Shareholders' Equity | 0.227 | 0.321 | 6.86 | 13.8 |
| Total Common Shares Outstanding |